PAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction Technology
April 13 2021 - 9:35AM
InvestorsHub NewsWire
Sandusky, OH --
April 13, 2021 -- InvestorsHub NewsWire -- PAO Group, Inc.
(USOTC:
PAOG) today released a management update on the company’s
ongoing CBD Pharmaceutical Development
Program.
Last year,
PAOG acquired
RespRx from Kali-Extracts, Inc. (OTC
Pink: KALY). RespRx is a CBD treatment under development for
Chronic Obstructive Pulmonary Disorder (COPD) derived from a
patented cannabis extraction method - U.S. Patent No. 9,199,960
entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT
MATERIALS INCLUDING THE CANNABIS
PLANT."
Since the
acquisition, PAOG engaged Veristat, a contract
research organization (CRO), dedicated to the clinical advance of
therapies and treatments through regulatory approval.
PAOG reports Veristat is making substantial progress in
validating and supplementing the underlying research behind
RespRx.
PAOG Expects New Research Funding And 25% Interest In
Cannabis Extraction
Patent
PAOG is in final
negotiations to enter into a partnership to conduct a CBD In Vivo
Histological Research Study advancing RespRx further through
regulatory approval. The partnership would include PAOG
gaining a 25% interest in the underlying Patented Cannabis
Extraction technology through which the RespRx formula is derived
and could result in PAOG owning the Patent outright. PAOG has
secured an investment commitment to fund the research and
partnership interest in the Patented Cannabis Extraction
technology.
The partnership
interest in the underlying Cannabis Extraction process would expand
PAOG’s pharmaceutical development reach potential beyond
RespRx,
For more
background on PAOG’s other CBD therapy developments, view a
comprehensive PAOG update recently released on the
company’s CBD
Nutraceutical Development Program with the first
PAOG CBD Nutraceutical products, packaged by Alkame Holdings, Inc.
(USOTC:
ALKM), expected to come to market before the end of this year
marketed through North American Cannabis Holdings, Inc. (USOTC:
USMJ).
Learn more about
PAOG at www.paogroupinc.com.
Forward-Looking
Statements: Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the company are
forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ
materially from those anticipated in such statements. Technical
complications, which may arise, could prevent the prompt
implementation of any strategically significant plan(s) outlined
above. The Company undertakes no duty to revise or update any
forward-looking statements to reflect events or circumstances after
the date of this release.
CONTACT
INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
info@pao.group
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Sep 2024 to Oct 2024
Kali (CE) (USOTC:KALY)
Historical Stock Chart
From Oct 2023 to Oct 2024